PCM
MSLI

Prelude Capital Management’s Merus Labs International Inc. MSLI Stock Holding History

Prelude Capital Management’s Portfolio MSLI Stock Details MSLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,510
Closed -$15K – 1992
2015
Q2 		$15K Buy
+6,510
New +$15.8K ﹤0.01% 1511

Other funds holding MSLI

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Prelude Capital Management's MSLI Position: Q3 2015 in Review

Prelude Capital Management sold out of Merus Labs International Inc. (MSLI) in Q3 2015, closing a stake of 6,510 shares — an estimated $15K sold.

Prelude Capital Management first reported a position in MSLI in Q2 2015 and held it in 1 quarter. The position peaked at $15K in Q2 2015. 29 funds tracked by Wall St. Rank hold MSLI as of Q3 2015.

  • Prelude Capital Management reported no remaining Merus Labs International Inc. position as of Q3 2015 after selling out during the quarter.
  • Prelude Capital Management sold 6,510 Merus Labs International Inc. shares in Q3 2015, an estimated $15K.
  • Prelude Capital Management first reported a position in Merus Labs International Inc. in Q2 2015 and held it in 1 quarter.
  • Prelude Capital Management's Merus Labs International Inc. position peaked at $15K in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2015.

Based on Prelude Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.